Express Pharma
Home  »  COVID-19 Updates  »  Inovio signs deal with Japan’s Kaneka for COVID-19 vaccine manufacturing

Inovio signs deal with Japan’s Kaneka for COVID-19 vaccine manufacturing

Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others

0 168
Read Article

Japan’s Kaneka Corp has entered into a deal to manufacture Inovio Pharmaceuticals’ COVID-19 vaccine candidate, informed the company.

It did not disclose the terms of the agreement with Kaneka Eurogentec, a unit of the Japanese chemical company.

Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others, to increase the supply of the vaccine, which entered a mid-stage study last month.

The Phase 3 of the mid-to-late stage study is under a partial hold by the US Food and Drug Administration as it seeks more information, including details on a delivery device used to inject genetic material into cells.

(Edits by EP News Bureau)

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Know Importance of using different levels of Controls
Register Now!
close-image